Mochida Pharmaceutical Co Ltd

Mochida Pharmaceutical Co Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (JPY)3,295.00
  • Today's Change60.00 / 1.85%
  • Shares traded32.10k
  • 1 Year change-16.90%
  • Beta0.5329
Data delayed at least 20 minutes, as of Mar 24 2023 06:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Events & Activity

  • 4534:TYO price moved over -1.19% to 3,330.00
  • 4534:TYO price falls below 200-day moving average to 3,345.00 at 09:01 BST

Key statistics

On Friday, Mochida Pharmaceutical Co Ltd (4534:TYO) closed at 3,295.00, 8.93% above its 52-week low of 3,025.00, set on May 27, 2022.
52-week range
3,025.00May 27 20224,000.00Mar 29 2022
Short selling activity
Provided by S&P Global Market Intelligence
Previous close3,235.00
Average volume47.37k
Shares outstanding38.50m
Free float27.39m
P/E (TTM)14.24
Market cap124.55bn JPY
EPS (TTM)227.17
Annual div (ADY)90.00
Annual div yield (ADY)2.73%
Div ex-dateSep 29 2022
Div pay-dateDec 01 2022
Data delayed at least 20 minutes, as of Mar 24 2023 06:00 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.